A Nanofibrous Macroencapsulation Device for Cell-Based Therapy: Evaluation of Biocompatibility and the Immunoisolation Function
Wang Kai,Hou Wenda,Luo Ying
DOI: https://doi.org/10.3389/conf.fbioe.2016.01.01287
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event A nanofibrous macroencapsulation device for cell-based therapy: evaluation of biocompatibility and the immunoisolation function Kai Wang1, Wenda Hou1* and Ying Luo1* 1 Peking university, Biomedical Engineering, China Introduction: Macroencapsulation devices shield the transplanted cells from the immune attack while facilitating the exchange of nutrients, oxygen and therapeutic products. The successful immunoisolation relies on the biocompatible semi-permeable membranes with the mildest foreign body reaction (FBR). Although nanofibrous materials mimic the extracellular matrix in terms of morphology and porosity, whether nanofibers can be used for cell-encapsulation applications remains uninvestigated. Here, we fabricated a membrane-based device using electrospun fibers and studied its biocompatibility and the function of isolating transplanted cells in rat/mouse models. Materials and Methods: Fibrous polyurethane (PU) membranes were manufactured with different fiber diameters using an electrospinning setup. The planar macroencapsulation device was fabricated by welding two layers of the electrospun membranes[1]. The electrospun membrane or cell-laden devices were then implanted subcutaneously in SD rats or C57BL/6 mice. The host FBRs to membranes were analyzed by histological study. Noninvasive bioluminscence imaging (BLI) was performed to monitor the cells within the device. Results and Discussion: The impact of fiber size and porosity on the FBR to electrospun membranes was investigated. When implanted subcutaneously alone, the microfibrous membranes were surrounded and infiltrated with macrophages and foreign body giant cells; in contrast, macrophages were scarce and only present on the surface of the nanofibrous membrane following a 2-month implantation. Moreover, significantly more blood vessels and thinner fibrotic capsules were found surrounding the nanofibrous implants compared to the microfibers samples. These results indicate the nanofibrous membrane not only possesses superior biocompatibility, but also can act as cell barrier to prevent cell invasion. By loading breast cancer cell lines (4T1-luc) in PU nanofibrous macroencapsulation devices and implanting the cells subcutaneously into allogenic mice (Fig. 1A), it is shown that the implanted cells survived and proliferated in vivo (Fig. 1B) up to 5 weeks. In another islet transplantation model in C57BL/6 mice, the encapsulated islets also survived and adapted to the encapsulation and implantation environment by reorganizing into four to five cell-thick flat layers within the device (Fig. 1C, D). The results indicate that although nanofibrous membranes prohibit cell invasion, they are able to support nutrients exchange and maintain the cell viability in vivo. Conclusions: Nanofibrous membranes are suitable materials to provide appropriate transport and biocompatibility properties for fabricating new immunoisolation devices. The encapsulated cells are useful for constructing artificial organs/models for cell therapy as well as fundamental immunology investigations. This research was financially supported by the Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), the National Natural Science Foundation of China (Project No. 31322021), and the Projects Grants of National Engineering Laboratory for Regenerative and Implantable Medical Devices (2012NELRMD003).References:[1] Wang K et al. The paracrine effects of adipose-derived stem cells on neovascularization and biocompatibility of a macroencapsulation device. Acta Biomater (2015),http://dx.doi.org/10.1016/j.actbio.2014.12.025 Keywords: in vivo, Implant, nanofiber, Biocompatibility Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: General Session Oral Topic: Biomaterials in immune response Citation: Wang K, Hou W and Luo Y (2016). A nanofibrous macroencapsulation device for cell-based therapy: evaluation of biocompatibility and the immunoisolation function. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01287 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. * Correspondence: Dr. Wenda Hou, Peking university, Biomedical Engineering, Beijing, China, houwenda_95@126.com Dr. Ying Luo, Peking university, Biomedical Engineering, Beijing, China, ying.luo@pku.edu.cn Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Kai Wang Wenda Hou Ying Luo Google Kai Wang Wenda Hou Ying Luo Google Scholar Kai Wang Wenda Hou Ying Luo PubMed Kai Wang Wenda Hou Ying Luo Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.